Ann: Information For Retail Shareholders, page-299

First 299 Last

Share
Profile

Follow
michaelbellamy

933 Posts.

61

09/12/23

13:26

Post #: 71362126
Share

Originally posted by dolcevita: ↑

The path to gaining FDA approval has been more difficult than for most and while it's natural to feel worn down, it's very important to be mindful of what makes the situation unique:
- novel stem cell based therapy so FDA had no precedent for it (this is crucial to appreciate... downrampers love to pretend the FDA had a clear pathway to approval but they did not)
- FDA chopping and changing their requirements (due to inexperience, incompetence and probably sheer bloodymindedness take your pick, especially when ignoring the advice of their own expert committees but getting suddenly finicky over batch assays when there is no issue with effectiveness of the actual therapy, so just fine tuning causing yet another delay)
- Covid19 throwing a spanner in the works of clinical trials (no need to go into this, patient trials were derailed even those involving ARDS because of a lack of patients who were not compromised by other drugs)
- Licensing Deal of the Year win/win partnership with Cephalon getting blown up by Teva takeover (Teva then succeeding in blowing itself up)
- opportunistic potential partners getting cold feet instead of staying the course probably because of the ridiculous obstacles above
- at key times such as this and the Nasdaq listing there have been short ladder attacks, misleading analyst reports (lest we forget Macquarie Investments, and Regal suddenly emerging as a major holder, when the analyst from Macquarie who had downramped MSB, suddenly turned up at Regal) so bad the company was forced to issue a corrective Ann, it goes on and on and ON

But sympathetic as I am with your long holdings and I am a LT holder too, it is IMO a mistake to shoot ALL of the blame onto SI and management when contending with the sheer magnitude of all of this.

It is epic.

If there were any missteps by our team, they pale into insignificance.

This is what I mean by keeping a sense of proportion. Especially when we are so close to getting this over the line as we have seen in the updates at the AGM. We only need one approval and it all starts to fall into place.

Please take a look at the accounts posted about people who held on and made serious money with game changing technologies. Think about how long CSL was under wraps within government before being listed and the game changing. There are very useful parallels there.

I am taking above my offer amount and backing this company because it's the ethical thing to do and it makes sense to do so. IMO.

Expand

hi Dolce
yes I am aware of all these circumstances
yes I am remaining a sh in hope and anticipation of approval.
No I am not taking up this offer I have enough!
My post was in response to Lopez suggesting there would be an announcement prior to cutoff date as the bod or ceo would foresee share price pressure
I doubt that happening.
Dolce ..I admire your 'take on all comers' at the moment to back msb CR but you are facing a tsunami.Take a rest
What will be will be
its in the hands of SI and FDA
Hopefully we can celebrate at the next AGM

MSB Price at posting: 28.5¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

VUL

Vulcan appoints investment bank and M&A veteran to board

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

There are more pages in this discussion • 243 more messages in this thread...

First 299 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 94.3¢		Change -0.018(1.82%)		Mkt cap ! $1.073B

Open	High	Low	Value	Volume
95.5¢	97.0¢	93.5¢	$890.6K	939.3K

Buyers (Bids)

No.	Vol.	Price($)
25	45493	94.0¢

Sellers (Offers)

Price($)	Vol.	No.
94.5¢	91344	40

View Market Depth

No.	Vol.	Price($)
26	60703	0.940
24	106056	0.935
17	163859	0.930
9	177764	0.925
14	499462	0.920

Price($)	Vol.	No.
0.945	88503	36
0.950	99811	15
0.955	184205	15
0.960	49341	5
0.965	86295	6

Last trade - 14.43pm 13/09/2024 (20 minute delay)

MSB (ASX) Chart

Ann: Information For Retail Shareholders, page-299

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Vulcan appoints investment bank and M&A veteran to board

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Utah authorities sign off on Anson's lithium extraction plans at Green River

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Information For Retail Shareholders, page-299

Top Stories

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Vulcan appoints investment bank and M&A veteran to board

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Utah authorities sign off on Anson's lithium extraction plans at Green River

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News